| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.67B | 34.48B | 34.20B | 31.67B | 32.94B | 30.60B |
| Gross Profit | 7.47B | 7.28B | 7.11B | 6.38B | 6.47B | 6.22B |
| EBITDA | 2.45B | 2.33B | 2.30B | 1.59B | 1.84B | 1.70B |
| Net Income | 1.42B | 1.11B | 1.25B | 851.00M | 841.00M | 758.00M |
Balance Sheet | ||||||
| Total Assets | 30.59B | 34.65B | 31.49B | 31.49B | 29.89B | 28.97B |
| Cash, Cash Equivalents and Short-Term Investments | 5.87B | 6.38B | 6.99B | 6.32B | 6.19B | 5.67B |
| Total Debt | 2.65B | 3.44B | 2.60B | 3.28B | 3.24B | 3.73B |
| Total Liabilities | 12.34B | 14.65B | 13.14B | 14.10B | 14.07B | 14.03B |
| Stockholders Equity | 18.12B | 19.86B | 18.20B | 17.26B | 15.70B | 14.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -566.00M | 1.22B | 223.00M | 1.41B | 894.00M |
| Operating Cash Flow | 0.00 | 1.13B | 2.82B | 1.25B | 2.23B | 1.61B |
| Investing Cash Flow | 0.00 | -1.46B | -1.26B | -627.00M | -772.00M | 651.00M |
| Financing Cash Flow | 0.00 | -477.00M | -933.00M | -600.00M | -900.00M | -1.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥3.71B | 3.64 | ― | 2.95% | 9.54% | 5.99% | |
71 Outperform | ¥13.71B | 16.40 | ― | 3.16% | -1.07% | -25.73% | |
65 Neutral | ¥10.74B | 9.17 | ― | 3.40% | 0.82% | -11.07% | |
62 Neutral | ¥19.15B | 33.91 | ― | 2.01% | 6.50% | 33.16% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | ¥8.60B | 2.04 | ― | 1.06% | 7.53% | 124.36% | |
44 Neutral | ¥451.43B | 436.21 | ― | 0.98% | 1.80% | -84.10% |